Transferrin receptors are highly expressed in cell surfaces of breast cancer, brain tumour glioblastoma and meningo-glioma as well as in myelogenous leukaemia (CML) cells compared to their corresponding normal cells. This evidence concerns the gene TFRC and chronic myelogenous leukemia, BCR-ABL1 positive.